DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced that John Bonfiglio, Ph.D., President and CEO, will discuss the Company’s dendritic cell-based immunotherapy technology and provide a general corporate overview at the upcoming BIO CEO & Investor conference, to be held at the Waldorf Astoria Hotel in New York City. The presentation will begin at 11:15 a.m. (EST) on Tuesday, February 13, 2007, in the Carnegie Suite.
